Defibrillation testing of the implantable cardioverter defibrillator: when, how, and by whom?
- PMID: 17684575
- PMCID: PMC1939869
Defibrillation testing of the implantable cardioverter defibrillator: when, how, and by whom?
Abstract
The implantable cardioverter-defibrillator (ICD) has become an integral part of treatment for a variety of patients with symptomatic, or at risk for, ventricular tachyarrhythmias. The ICD's effectiveness is attributed to its ability to promptly detect and terminate ventricular tachycardia (VT) and fibrillation (VF). The clinical trials that established the positive role of ICD therapy were based on patients who underwent some form of defibrillation testing at the time of implantation. Therefore, since its advent, intraoperative defibrillation testing of the ICD to assure reliable detection and termination of VT/VF has been a standard practice. But because of advances in defibrillator and lead technology, which now facilitates successful device implantation (i.e., low defibrillation energy requirement to allow for an adequate programmed safety margin) in the majority of patients, the necessity of defibrillation testing has been called into attention. Despite substantial progress, it is not altogether clear whether a wholesale abandonment of intraoperative ICD testing is appropriate at this point. We review pertinent data regarding pros and cons of ICD testing and offer a suggestion as to when, how, and who should test ICDs.
Figures



Similar articles
-
Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).Circulation. 2007 May 8;115(18):2382-9. doi: 10.1161/CIRCULATIONAHA.106.663112. Epub 2007 Apr 30. Circulation. 2007. PMID: 17470697 Clinical Trial.
-
The NO Regular Defibrillation testing In Cardioverter Defibrillator Implantation (NORDIC ICD) trial: concept and design of a randomized, controlled trial of intra-operative defibrillation testing during de novo defibrillator implantation.Europace. 2015 Jan;17(1):142-7. doi: 10.1093/europace/euu161. Epub 2014 Aug 8. Europace. 2015. PMID: 25107947 Clinical Trial.
-
Defibrillation Testing During Defibrillator Implantation.Arrhythm Electrophysiol Rev. 2012 Sep;1(1):51-53. doi: 10.15420/aer.2012.1.51. Arrhythm Electrophysiol Rev. 2012. PMID: 26835030 Free PMC article.
-
The dilemma of ICD implant testing.Pacing Clin Electrophysiol. 2007 May;30(5):675-700. doi: 10.1111/j.1540-8159.2007.00730.x. Pacing Clin Electrophysiol. 2007. PMID: 17461879 Review.
-
Implantable Cardioverter Defibrillator Implantation with or Without Defibrillation Testing.Card Electrophysiol Clin. 2018 Mar;10(1):119-125. doi: 10.1016/j.ccep.2017.11.012. Epub 2017 Dec 14. Card Electrophysiol Clin. 2018. PMID: 29428133
Cited by
-
Implantation of additional subcutaneous array electrode reduces defibrillation threshold in ICD patients - preliminary results.Arch Med Sci. 2013 Jun 20;9(3):440-4. doi: 10.5114/aoms.2013.35480. Epub 2013 Jun 21. Arch Med Sci. 2013. PMID: 23847664 Free PMC article.
-
Analysis of Temporal Trends and Variation in the Use of Defibrillation Testing in Contemporary Practice.JAMA Netw Open. 2019 Oct 2;2(10):e1913553. doi: 10.1001/jamanetworkopen.2019.13553. JAMA Netw Open. 2019. PMID: 31626314 Free PMC article.
-
Critical analysis of ineffective post implantation implantable cardioverter-defibrillator-testing.World J Cardiol. 2017 Feb 26;9(2):167-173. doi: 10.4330/wjc.v9.i2.167. World J Cardiol. 2017. PMID: 28289531 Free PMC article.
-
ICD implantation without intraoperative testing does not increase the rate of system modifications and does not impair defibrillation efficacy tested in follow-up.Herzschrittmacherther Elektrophysiol. 2013 Jun;24(2):125-30. doi: 10.1007/s00399-013-0267-5. Epub 2013 Jun 7. Herzschrittmacherther Elektrophysiol. 2013. PMID: 23744101 Clinical Trial.
-
The relationship between defibrillation threshold and total mortality.J Interv Card Electrophysiol. 2013 Dec;38(3):203-8. doi: 10.1007/s10840-013-9831-5. Epub 2013 Oct 22. J Interv Card Electrophysiol. 2013. PMID: 24146190
References
-
- Connolly SJ, Hallstrom AP, Cappato R, et al. Metanalysis of the implantable cardioverter defibrillator secondary prevention trials: AVID, CASH and CIDS studies. Eur heart J. 2000;21:2071–2078. - PubMed
-
- Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 1996;335:1933–1940. - PubMed
-
- Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med. 1999;341:1882–1890. - PubMed
-
- Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction (The Multicenter Automatic Defibrillator Trial II) N Engl J Med. 2002;346:877–883. - PubMed
-
- Gregoratos G, Abrams J, Epstein AE. ACC/AHA/NASPE 2002 Guideline update for implantation of cardiac pacemakers and antiarrhythmic devices - summary article. J Am Coll Cardiol. 2002;40:1703–1719. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous